Global Biologic Drugs Sales Market Report 2018

July 2018 | 107 pages | ID: G1E7ABD0FB9EN
QYResearch

Abstracts

This report studies the global Biologic Drugs market status and forecast, categorizes the global Biologic Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Biologic Drugs market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report

• Roche
• Abbott Laboratories
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Amgen
• Sanofi
• Novartis
• Eli Lilly
• Amgen

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Humira
• Remicade
• Rituxan
• Enbrel
• Lantus
• Avastin
• Herceptin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Diabetes
• Inflammation
• Auto-Immune Diseases
• Blood Diseases
• Cardiovascular Diseases
• Others

The study objectives of this report are:

• To analyze and study the global Biologic Drugs sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Biologic Drugs players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologic Drugs are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biologic Drugs Manufacturers
Biologic Drugs Distributors/Traders/Wholesalers
Biologic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the Biologic Drugs market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global Biologic Drugs Sales Market Report 2018

1 BIOLOGIC DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologic Drugs
1.2 Classification of Biologic Drugs by Product Category
  1.2.1 Global Biologic Drugs Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Biologic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Humira
  1.2.4 Remicade
  1.2.5 Rituxan
  1.2.6 Enbrel
  1.2.7 Lantus
  1.2.8 Avastin
  1.2.9 Herceptin
  1.2.10 Others
1.3 Global Biologic Drugs Market by Application/End Users
  1.3.1 Global Biologic Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Diabetes
  1.3.2 Inflammation
  1.3.3 Auto-Immune Diseases
  1.3.4 Blood Diseases
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Global Biologic Drugs Market by Region
  1.4.1 Global Biologic Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Biologic Drugs Status and Prospect (2013-2025)
  1.4.3 Europe Biologic Drugs Status and Prospect (2013-2025)
  1.4.4 China Biologic Drugs Status and Prospect (2013-2025)
  1.4.5 Japan Biologic Drugs Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Biologic Drugs Status and Prospect (2013-2025)
  1.4.7 India Biologic Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Biologic Drugs (2013-2025)
  1.5.1 Global Biologic Drugs Sales and Growth Rate (2013-2025)
  1.5.2 Global Biologic Drugs Revenue and Growth Rate (2013-2025)

2 GLOBAL BIOLOGIC DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Biologic Drugs Market Competition by Players/Suppliers
  2.1.1 Global Biologic Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Biologic Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Biologic Drugs (Volume and Value) by Type
  2.2.1 Global Biologic Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 Global Biologic Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Biologic Drugs (Volume and Value) by Region
  2.3.1 Global Biologic Drugs Sales and Market Share by Region (2013-2018)
  2.3.2 Global Biologic Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Biologic Drugs (Volume) by Application

3 UNITED STATES BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biologic Drugs Sales and Value (2013-2018)
  3.1.1 United States Biologic Drugs Sales and Growth Rate (2013-2018)
  3.1.2 United States Biologic Drugs Revenue and Growth Rate (2013-2018)
  3.1.3 United States Biologic Drugs Sales Price Trend (2013-2018)
3.2 United States Biologic Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Biologic Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Biologic Drugs Sales Volume and Market Share by Application (2013-2018)

4 EUROPE BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Biologic Drugs Sales and Value (2013-2018)
  4.1.1 Europe Biologic Drugs Sales and Growth Rate (2013-2018)
  4.1.2 Europe Biologic Drugs Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Biologic Drugs Sales Price Trend (2013-2018)
4.2 Europe Biologic Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Biologic Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Biologic Drugs Sales Volume and Market Share by Application (2013-2018)

5 CHINA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 China Biologic Drugs Sales and Value (2013-2018)
  5.1.1 China Biologic Drugs Sales and Growth Rate (2013-2018)
  5.1.2 China Biologic Drugs Revenue and Growth Rate (2013-2018)
  5.1.3 China Biologic Drugs Sales Price Trend (2013-2018)
5.2 China Biologic Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Biologic Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Biologic Drugs Sales Volume and Market Share by Application (2013-2018)

6 JAPAN BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biologic Drugs Sales and Value (2013-2018)
  6.1.1 Japan Biologic Drugs Sales and Growth Rate (2013-2018)
  6.1.2 Japan Biologic Drugs Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Biologic Drugs Sales Price Trend (2013-2018)
6.2 Japan Biologic Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Biologic Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Biologic Drugs Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biologic Drugs Sales and Value (2013-2018)
  7.1.1 Southeast Asia Biologic Drugs Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Biologic Drugs Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Biologic Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Biologic Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Biologic Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Biologic Drugs Sales Volume and Market Share by Application (2013-2018)

8 INDIA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Biologic Drugs Sales and Value (2013-2018)
  8.1.1 India Biologic Drugs Sales and Growth Rate (2013-2018)
  8.1.2 India Biologic Drugs Revenue and Growth Rate (2013-2018)
  8.1.3 India Biologic Drugs Sales Price Trend (2013-2018)
8.2 India Biologic Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Biologic Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Biologic Drugs Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL BIOLOGIC DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Roche
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biologic Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biologic Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Johnson & Johnson
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biologic Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Merck & Co.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biologic Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Pfizer
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Biologic Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Amgen
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Biologic Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Sanofi
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Biologic Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Novartis
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Biologic Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Eli Lilly
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Biologic Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Amgen
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Biologic Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview

10 BIOLOGIC DRUGS MAUFACTURING COST ANALYSIS

10.1 Biologic Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biologic Drugs
10.3 Manufacturing Process Analysis of Biologic Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biologic Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologic Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOLOGIC DRUGS MARKET FORECAST (2018-2025)

14.1 Global Biologic Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Biologic Drugs Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Biologic Drugs Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Biologic Drugs Price and Trend Forecast (2018-2025)
14.2 Global Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Biologic Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Biologic Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Biologic Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Biologic Drugs Sales Forecast by Type (2018-2025)
  14.3.2 Global Biologic Drugs Revenue Forecast by Type (2018-2025)
  14.3.3 Global Biologic Drugs Price Forecast by Type (2018-2025)
14.4 Global Biologic Drugs Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biologic Drugs
Figure Global Biologic Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Biologic Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Humira Product Picture
Figure Remicade Product Picture
Figure Rituxan Product Picture
Figure Enbrel Product Picture
Figure Lantus Product Picture
Figure Avastin Product Picture
Figure Herceptin Product Picture
Figure Others Product Picture
Figure Global Biologic Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Biologic Drugs by Application in 2017
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Auto-Immune Diseases Examples
Table Key Downstream Customer in Auto-Immune Diseases
Figure Blood Diseases Examples
Table Key Downstream Customer in Blood Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Biologic Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biologic Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Biologic Drugs Sales Volume (K Units) (2013-2018)
Table Global Biologic Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Biologic Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Biologic Drugs Sales Share by Players/Suppliers
Figure 2017 Biologic Drugs Sales Share by Players/Suppliers
Figure Global Biologic Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biologic Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biologic Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Biologic Drugs Revenue Share by Players
Table 2017 Global Biologic Drugs Revenue Share by Players
Table Global Biologic Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Biologic Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Biologic Drugs by Type (2013-2018)
Figure Global Biologic Drugs Sales Growth Rate by Type (2013-2018)
Table Global Biologic Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Biologic Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biologic Drugs by Type (2013-2018)
Figure Global Biologic Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Biologic Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Biologic Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Biologic Drugs by Region (2013-2018)
Figure Global Biologic Drugs Sales Growth Rate by Region in 2017
Table Global Biologic Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biologic Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biologic Drugs by Region (2013-2018)
Figure Global Biologic Drugs Revenue Growth Rate by Region in 2017
Table Global Biologic Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biologic Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biologic Drugs by Region (2013-2018)
Figure Global Biologic Drugs Revenue Market Share by Region in 2017
Table Global Biologic Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Biologic Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Biologic Drugs by Application (2013-2018)
Figure Global Biologic Drugs Sales Market Share by Application (2013-2018)
Figure United States Biologic Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Biologic Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Biologic Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Biologic Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Biologic Drugs Sales Volume Market Share by Players in 2017
Table United States Biologic Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Biologic Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Biologic Drugs Sales Volume Market Share by Type in 2017
Table United States Biologic Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Biologic Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Biologic Drugs Sales Volume Market Share by Application in 2017
Figure Europe Biologic Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Biologic Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Biologic Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Biologic Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Biologic Drugs Sales Volume Market Share by Players in 2017
Table Europe Biologic Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Biologic Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Biologic Drugs Sales Volume Market Share by Type in 2017
Table Europe Biologic Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Biologic Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Biologic Drugs Sales Volume Market Share by Application in 2017
Figure China Biologic Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Biologic Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Biologic Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Biologic Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Biologic Drugs Sales Volume Market Share by Players in 2017
Table China Biologic Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Biologic Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Biologic Drugs Sales Volume Market Share by Type in 2017
Table China Biologic Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Biologic Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Biologic Drugs Sales Volume Market Share by Application in 2017
Figure Japan Biologic Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Biologic Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Biologic Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Biologic Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Biologic Drugs Sales Volume Market Share by Players in 2017
Table Japan Biologic Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Biologic Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Biologic Drugs Sales Volume Market Share by Type in 2017
Table Japan Biologic Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Biologic Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Biologic Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Biologic Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Biologic Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Application in 2017
Figure India Biologic Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Biologic Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Biologic Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Biologic Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Biologic Drugs Sales Volume Market Share by Players in 2017
Table India Biologic Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Biologic Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Biologic Drugs Sales Volume Market Share by Type in 2017
Table India Biologic Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Biologic Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Biologic Drugs Sales Volume Market Share by Application in 2017
Table Roche Basic Information List
Table Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologic Drugs Sales Growth Rate (2013-2018)
Figure Roche Biologic Drugs Sales Global Market Share (2013-2018)
Figure Roche Biologic Drugs Revenue Global Market Share (2013-2018)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Laboratories Biologic Drugs Sales Growth Rate (2013-2018)
Figure Abbott Laboratories Biologic Drugs Sales Global Market Share (2013-2018)
Figure Abbott Laboratories Biologic Drugs Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologic Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Biologic Drugs Sales Global Market Share (2013-2018
Figure Johnson & Johnson Biologic Drugs Revenue Global Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co. Biologic Drugs Sales Growth Rate (2013-2018)
Figure Merck & Co. Biologic Drugs Sales Global Market Share (2013-2018)
Figure Merck & Co. Biologic Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Biologic Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Biologic Drugs Sales Global Market Share (2013-2018)
Figure Pfizer Biologic Drugs Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologic Drugs Sales Growth Rate (2013-2018)
Figure Amgen Biologic Drugs Sales Global Market Share (2013-2018
Figure Amgen Biologic Drugs Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologic Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Biologic Drugs Sales Global Market Share (2013-2018)
Figure Sanofi Biologic Drugs Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologic Drugs Sales Growth Rate (2013-2018)
Figure Novartis Biologic Drugs Sales Global Market Share (2013-2018
Figure Novartis Biologic Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Biologic Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Biologic Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Biologic Drugs Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologic Drugs Sales Growth Rate (2013-2018)
Figure Amgen Biologic Drugs Sales Global Market Share (2013-2018)
Figure Amgen Biologic Drugs Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologic Drugs
Figure Manufacturing Process Analysis of Biologic Drugs
Figure Biologic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Biologic Drugs Major Players in 2017
Table Major Buyers of Biologic Drugs
Table Distributors/Traders List
Figure Global Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biologic Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Biologic Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Biologic Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Biologic Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Biologic Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Biologic Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Biologic Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Biologic Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Biologic Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Biologic Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Biologic Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biologic Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Biologic Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Biologic Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Biologic Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources